Visit More ASCA Sites:
As part of its ongoing investigation of the multistate outbreak of fungal infections, the Centers for Disease Control and Prevention (CDC) continues to assess and revise interim guidance to clinicians involved in the management of patients who received injections with contaminated steroid products distributed by the New England Compounding Center (NECC).
The Atrium Building277 S Washington St.Ste 375Alexandria, VA 22314
703.836.8808
asc@ascassociation.org
Medicare Resources
ASC Operations
Education & Events
Membership
About ASCs
News & Publications
Code of Conduct
Privacy Policy
Terms of Use
About ASCA
Join/Renew
Find an ASC
Get Involved
Marketing Opportunities
Contact Us